- Home
- FA vs SRPT Comparison
FA vs SRPT Comparison
Compare FA & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FA
- SRPT
- Stock Information
- Founded
- FA 2003
- SRPT 1980
- Country
- FA United States
- SRPT United States
- Employees
- FA 10000
- SRPT N/A
- Industry
- FA Business Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- FA Consumer Discretionary
- SRPT Health Care
- Exchange
- FA Nasdaq
- SRPT Nasdaq
- Market Cap
- FA 2.2B
- SRPT 1.9B
- IPO Year
- FA 2021
- SRPT 1997
- Fundamental
- Price
- FA $14.14
- SRPT $17.57
- Analyst Decision
- FA Buy
- SRPT Hold
- Analyst Count
- FA 4
- SRPT 30
- Target Price
- FA $20.67
- SRPT $35.93
- AVG Volume (30 Days)
- FA 784.0K
- SRPT 6.0M
- Earning Date
- FA 11-06-2025
- SRPT 11-03-2025
- Dividend Yield
- FA N/A
- SRPT N/A
- EPS Growth
- FA N/A
- SRPT N/A
- EPS
- FA N/A
- SRPT N/A
- Revenue
- FA $1,251,464,000.00
- SRPT $2,413,715,000.00
- Revenue This Year
- FA $84.14
- SRPT $10.20
- Revenue Next Year
- FA $5.93
- SRPT N/A
- P/E Ratio
- FA N/A
- SRPT N/A
- Revenue Growth
- FA 65.34
- SRPT 47.15
- 52 Week Low
- FA $12.25
- SRPT $10.42
- 52 Week High
- FA $20.79
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- FA 49.60
- SRPT 38.85
- Support Level
- FA $12.25
- SRPT $15.08
- Resistance Level
- FA $14.75
- SRPT $18.80
- Average True Range (ATR)
- FA 0.55
- SRPT 1.35
- MACD
- FA -0.01
- SRPT -0.78
- Stochastic Oscillator
- FA 70.40
- SRPT 27.46
About FA First Advantage Corporation
First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.